StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) stock

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$11.97−0.47 (-3.78%)

Close on Nov 20, 2026Market cap $1.12BP/E –Yield –

Ascentage Pharma Group International net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -CN¥1.24B.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CN¥1.24B–
FY2024Dec 31, 2024-CN¥405.43M–
FY2023Dec 31, 2023-CN¥925.64M–
FY2022Dec 31, 2022-CN¥882.92M–

More Ascentage Pharma Group International figures

See a number that looks wrong?